Markets:

News

Articles published by Prokarium

Prokarium Reports Positive Interim Data from Phase 1/1b PARADIGM-1 trial of ZH9 in NMIBC patients, Demonstrating Excellent Safety and Encouraging Early Efficacy

Today 3:00 EDT

From Prokarium

Via Business Wire

Prokarium Appoints Ibs Mahmood as Chief Executive Officer

November 11, 2025

From Prokarium

Via Business Wire

Prokarium Expands IP Portfolio With Two New U.S. Patents Strengthening Its Position in Bladder Cancer

November 01, 2024

From Prokarium

Via Business Wire

Prokarium Achieves Milestone with First Patient Dosing in PARADIGM-1 Non-Muscle Invasive Bladder Cancer Clinical Trial

February 07, 2024

From Prokarium

Via Business Wire

Prokarium Achieves Major Milestone with FDA's IND Approval for Bladder Cancer Program

November 02, 2023

From Prokarium

Via Business Wire

Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic and Build Novel Therapeutic Platform

February 09, 2023

From Prokarium

Via Business Wire

Prokarium Strengthens Patent Position Through Notice of Allowance of US Patent for Immunotherapy Prime in Combination with Cell Therapies

October 05, 2022

From Prokarium

Via Business Wire

Prokarium Expands R&D Capabilities with London Biofoundry to Deepen Microbial Immunotherapy Pipeline

January 26, 2022

From Prokarium

Via Business Wire

Prokarium Shares Preclinical Proof-of-Concept Data on Its Microbial Immunotherapy Bladder Cancer Program at SITC 2021

November 11, 2021

From Prokarium

Via Business Wire

Prokarium Promotes Livija Deban to Chief Scientific Officer to Drive Pipeline Expansion in Cancer Immunotherapy

November 02, 2021

From Prokarium

Via Business Wire

Prokarium Appoints Industry Veteran Thomas Eldered as Chairman of the Board

October 05, 2021

From Prokarium

Via Business Wire

Prokarium Appoints Uz Stammberger as Chief Medical Officer to Drive Clinical Development in Oncology

July 29, 2021

From Prokarium

Via Business Wire

Prokarium Appoints Kristen Albright as Chief Executive Officer

July 27, 2021

From Prokarium

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.